雄岸科技(01647.HK)擬收購素麻生物51%股權
格隆匯11月22日丨雄岸科技(01647.HK)發佈公告, 2019年11月22日,公司、漢麻投資集團有限公司及雲南素麻生物科技有限公司訂立股權轉讓框架協議。根據框架協議,公司擬收購及漢麻集團擬出售於素麻生物的51%股權。於公告日期,漢麻集團為素麻生物的控股公司。
可能收購事項的代價將通過向漢麻集團或其所指定的團體配發及發行公司的新股份的方式償付。
根據漢麻集團所提供的資料,漢麻集團專注於工業大麻產業鏈的投資。其業務涵蓋由工業大麻種植及花葉處理,以至開發基於工業大麻活性成分的醫藥產品。根據漢麻集團所提供的資料,素麻生物於2016年根據《中華人民共和國公司法》成立。其已取得工業大麻相關業務行政許可,而其業務範圍包括(i)工業大麻及籽種的科學研究、培育、種植、加工及其產品的銷售;(ii)農副產品收購及銷售;(iii)生物技術的開發應用;及 (iv)貨物及技術出口業務。
董事會認為,可能收購事項將為公司於中國進行工業大麻種植及加工業務以及工業大麻產業鏈佈局奠定良好的基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.